Triclabendazole

(Egaten®)

Egaten®

Drug updated on 12/19/2023

Dosage FormTablet (oral: 250 mg)
Drug ClassAntihelmintics
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For the treatment of fascioliasis in patients 6 years of age and older.

Product Monograph / Prescribing Information

Document TitleYearSource
Egaten (triclabendazole) Prescribing Information.2022Novartis Pharmaceuticals Corporation, East Hanover, NJ

Randomized Controlled Trials


Sex Distribution:

F:51%
M:49%
59Subjects

Year:

2015

Source:Revista da Sociedade Brasileira de Medicina Tropical